Penilaian Kinerja Berdasarkan Perspektif Balanced Scorecard Untuk Penerapan Remunerasi Pada Rs. Mata Cicendo Bandung
Jurnal Media Administrasi Terapan · 2022
DOI: 10.31113/jmat.v2i2.24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jurnal Media Administrasi Terapan, 2022. Verfasst von Rofik Sandra Herdian und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
This research is about performance assessment from the balanced scorecard perspective in the framework of remuneration implementation at the Eye Hospital Cicendo Bandung. It aims to identify and analyze the employee performance at the Eye Hospital Cicendo Bandung by using 4 (four) balanced scorecard indicators. It also tries to figure out the remuneration implementation at the Eye Hospital Cicendo Bandung. This research employed a descriptive qualitative method. The data were collected through library research, interviews, and document reviews. In general, the performance assessment using the four balanced scorecard perspectives at Cicendo Eye Hospital Bandung showed good performance results. This can be seen from the achievements of each indicator in the four balanced scorecard perspectives.
Zitieren
APA
Herdian, R. S., Lestari, E. W. T., & Sufianti, E. (2022). Penilaian Kinerja Berdasarkan Perspektif Balanced Scorecard Untuk Penerapan Remunerasi Pada Rs. Mata Cicendo Bandung. Jurnal Media Administrasi Terapan. https://doi.org/10.31113/jmat.v2i2.24
Vancouver
Herdian RS, Lestari EWT, Sufianti E. Penilaian Kinerja Berdasarkan Perspektif Balanced Scorecard Untuk Penerapan Remunerasi Pada Rs. Mata Cicendo Bandung. Jurnal Media Administrasi Terapan. 2022. doi:10.31113/jmat.v2i2.24
BibTeX
@article{Herdian2022,
author = {Herdian, Rofik Sandra and Lestari, Endang Wirjatmi Tri and Sufianti, Ely},
title = {Penilaian Kinerja Berdasarkan Perspektif Balanced Scorecard Untuk Penerapan Remunerasi Pada Rs. Mata Cicendo Bandung},
journal = {Jurnal Media Administrasi Terapan},
year = {2022},
doi = {10.31113/jmat.v2i2.24}
}
EUVIMED